Pomalidomide Capsule
Product Images NDC 43598-519

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Pomalidomide (NDC 43598-519). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Dr. Reddy's Laboratories Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Container1 (Container1)

Container1 (Container1)
Pomalidomide Capsules 1 mg oral dosage form label from Dr. Reddy's Laboratories Inc. The label includes the NDC 43598-520-21, a warning about potential human birth defects, storage instructions at 20°C to 25°C (68°F to 77°F), and dispensing information. The package contains 21 capsules. Barcode and manufacturing details are also visible.*
FDA Label Image

Container2 (Container2)

Container2 (Container2)
Pomalidomide Capsules 2 mg oral dosage form label from Dr. Reddy's Laboratories Inc. The carton label indicates 21 capsules per package, with a warning about potential human birth defects. Instructions mention storage at controlled room temperature (20° to 25°C) and dosage guidance per prescribing information. The label includes barcode, batch, and expiration fields.*
FDA Label Image

Container3 (Container3)

Container3 (Container3)
Label for pomalidomide capsules 3 mg, oral dosage form, packaged with 21 capsules. The label shows Dr. Reddy's Laboratories Inc. as the distributor and states the product is Made in India. It includes a warning about the potential for human birth defects and storage instructions. The label also features a barcode and placeholders for serial number, expiry date, and batch number.*
FDA Label Image

Container4 (Container4)

Container4 (Container4)
Pomalidomide Capsules 4 mg label from Dr. Reddy's Laboratories Inc. The label includes dosage strength, a warning about potential human birth defects, and storage instructions. It mentions that each capsule contains 4 mg of pomalidomide, and the package contains 21 capsules. The label also states 'Rx only' and includes a barcode, distributor information, and lot details placeholder.*
FDA Label Image

Figure1 (Figure1)

Figure1 (Figure1)
A Kaplan-Meier survival curve chart comparing progression-free survival over months between two groups: HD-DEX alone (blue line) and Pomalidomide plus LD-DEX (red dashed line). The vertical axis shows the proportion of subjects, and the horizontal axis shows time in months. Below the chart, a table lists the number of subjects at risk over time for each group.*
FDA Label Image

Figure2 (Figure2)

Figure2 (Figure2)
A Kaplan-Meier survival curve showing overall survival (months) comparing two treatment groups: HD-DEX (blue solid line) and Pomalidomide plus LD-DEX (red dashed line). The Y-axis represents the proportion of subjects surviving. A table below lists the number of subjects at risk over time for each group.*
FDA Label Image
Logo (Logo)
Chemical structure of pomalidomide active ingredient depicted as a 2D molecular diagram. The structure shows rings and bonds representing the chemical configuration of pomalidomide.*
FDA Label Image

Structure (Structure)

Structure (Structure)
Chemical structure of pomalidomide showing its molecular framework with an amino group on an aromatic ring, multiple carbonyl groups, and a glutarimide ring system.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.